Capital Change - The company has approved a change in registered capital from RMB 100,486,640 to RMB 140,219,804, reflecting an increase due to a capital reserve conversion and cash dividends distribution [1][4][6] - The total number of shares will increase from 100,486,640 to 140,219,804 shares, with a cash dividend of RMB 3 per 10 shares distributed to shareholders, totaling RMB 29,799,873.60 [1][4][6] Business Scope Change - The company's business scope has been updated to include the development and manufacturing of smart water systems, smart instruments, industrial automation control systems, environmental protection equipment, and smart robots, among others [2][5] - The revised business scope also encompasses services related to water resource management, environmental monitoring, and big data services, reflecting a broader operational focus [2][5] Articles of Association Revision - The company's Articles of Association will be amended to reflect the changes in registered capital and business scope, with specific clauses updated accordingly [3][4][6] - Other provisions in the Articles of Association will remain unchanged, ensuring continuity in governance while adapting to the new operational framework [6]

Core Insights - The Ministry of Commerce announced that from January to May 2025, a total of 24,018 new foreign-invested enterprises were established in China, representing a year-on-year increase of 10.4% [1] - However, the actual utilized foreign capital amounted to 358.19 billion RMB, showing a year-on-year decrease of 13.2% [1] Industry Analysis - In terms of industry, the actual utilized foreign capital in the manufacturing sector was 91.52 billion RMB, while the service sector saw 259.64 billion RMB [1] - High-tech industries attracted 109.04 billion RMB in actual foreign investment, with significant growth in specific sectors: e-commerce services increased by 146%, aerospace equipment manufacturing by 74.9%, chemical pharmaceuticals by 59.2%, and medical instruments and devices by 20% [1] Source Region Insights - From the perspective of source regions, foreign investment from ASEAN countries grew by 20.5% [1] - Investments from Japan, the UK, South Korea, and Germany increased by 70.2%, 60.9%, 10.3%, and 7.1% respectively [1]

上海市锦天城律师事务所 关于南京茂莱光学科技股份有限公司 向不特定对象发行可转换公司债券的 补充法律意见书（一） 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 补充法律意见书（一） 目 录 上海市锦天城律师事务所 关于南京茂莱光学科技股份有限公司 向不特定对象发行可转换公司债券的 补充法律意见书（一） 致：南京茂莱光学科技股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受南京茂莱光学科技股份 有限公司（以下简称"发行人"或"公司"或"茂莱光学"）的委托，并根据发 行人与本所签订的《专项法律服务合同》，作为发行人向不特定对象发行可转换 公司债券（以下简称"本次发行"）工作的特聘专项法律顾问。 本所已根据相关法律、法规、规章及规范性文件的规定并按照律师行业公认 的业务标准、道德规范和勤勉尽责的查验原则，对发行人已经提供的与本次发行 有关的文件和有关事实进行了核查和验证，并于 2025 年 4 月 21 日出具《上海市 锦天城律师事务所关于南京茂莱光学科技股份有限公司向不 ...

Core Viewpoint - The article highlights the resilience and innovative vitality of China's scientific instrument industry in the face of global challenges, showcasing significant growth in overseas revenue among domestic listed companies [2][6]. Group 1: Overview of Overseas Revenue - In 2024, the total overseas revenue of 43 domestic listed instrument companies reached 34.707 billion yuan, marking a new high [6][10]. - Over 60% of the companies reported revenue growth, with 21 companies achieving over 100 million yuan in overseas revenue [6][10]. - The top five companies by overseas revenue are Mindray Medical (16.434 billion yuan), Sunny Optical (9.602 billion yuan), Libang Instruments (1.098 billion yuan), BGI Genomics (913 million yuan), and Huashengchang (717 million yuan) [3][6]. Group 2: Performance Analysis - Among the 43 companies, 27 experienced stable or significant growth, with notable examples including Wanyi Technology, which saw a 447.23% increase in overseas revenue [7][12]. - Conversely, 14 companies faced revenue declines, such as Gaode Infrared, which reported a 50.76% drop [7][15]. - Mindray Medical's overseas revenue accounted for 44.75% of its total revenue, reflecting the effectiveness of its globalization strategy [10][17]. Group 3: Market Dynamics - The article indicates a shift in the market, with three companies achieving over 1 billion yuan in overseas revenue, while 18 companies fall within the 100 million to 1 billion yuan range [13]. - Companies with overseas revenue constituting over 10% of total revenue increased to 22, indicating a growing trend in international market engagement [17]. - Wanyi Technology's strategy of "product leadership, quality excellence, competitive pricing, and superior service" has led to substantial growth in overseas markets [13][17]. Group 4: Emerging Companies - New entrants like Titan Technology and Lihua Technology reported 100% growth in overseas revenue, reflecting successful market expansion strategies [14]. - Titan Technology leveraged partnerships with overseas distributors and acquisitions to enhance its competitive brand presence [14]. Group 5: Future Outlook - Despite external uncertainties, the overall trend indicates a robust commitment from Chinese companies to expand in international markets, suggesting a "fast forward" approach to globalization [17].

青岛华航环境科技有限责任公司，成立于2014年，位于青岛市，是一家以从事仪器仪表制造业为主的企 业。企业注册资本2215万人民币。通过天眼查大数据分析，青岛华航环境科技有限责任公司共对外投资 了1家企业，参与招投标项目151次，财产线索方面有商标信息3条，专利信息26条，此外企业还拥有行 政许可6个。 上海雷探科技有限公司，成立于2017年，位于上海市，是一家以从事科技推广和应用服务业为主的企 业。企业注册资本500万人民币。通过天眼查大数据分析，上海雷探科技有限公司参与招投标项目48 次，财产线索方面有商标信息3条，专利信息33条，此外企业还拥有行政许可2个。 来源：金融界 金融界2025年6月20日消息，国家知识产权局信息显示，中国长江三峡集团有限公司、上海勘测设计研 究院有限公司、青岛华航环境科技有限责任公司、上海雷探科技有限公司取得一项名为"一种海上风能 资源探测装置"的专利，授权公告号CN115523384B，申请日期为2022年10月。 天眼查资料显示，中国长江三峡集团有限公司，成立于1993年，位于武汉市，是一家以从事电力、热力 生产和供应业为主的企业。企业注册资本21150000万人民币。通过 ...

导读： 2024年国产仪器行业营收分化，头部企业如安图生物逆势增长，高分红拉大老板收入差距，出海战略成关键驱动力，环境监测与工业过程领域面临挑战， 成本压力加剧。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 在宏观经济增速换挡与产业升级并行的2024年，国产仪器行业整体营收呈现显著分化特征： 头部企业通过战略调整实现逆势增长，部分领域 则因市场收缩与成本压力陷入困境。 在此背景下，仪器信息网聚焦14家代表性企业，通过分析其财务数据，从企业领导者收入情况入手，深入 透视行业发展与企业治理的共性。 备 注 ： 收 入 = 薪 酬 + 分 红 ； 薪 酬 指 报 告 期 内 从 公 司 获 得 的 税 前 薪 酬 ； 分 红 指 派 发 的 现 金 红 利 。 国内上市仪器公司老板们的收入主要由报告期内从公司获得的税前薪酬（基础薪酬）以及向股东派发的现金红利两部分构成。本次统计的14家 企业老板收入，相比去年，收入极差进一步拉大。 高收入主要是由于高分红。 安图生物董事长苗拥军是今年唯一收入破亿的老板，且已连续两年达到这一水平（去年收入1.3 ...

Core Viewpoint - Fuhuang Steel Structure (002743.SZ) announced the termination of its plan to issue shares and pay cash for asset acquisition, citing changes in market conditions and transaction cycles as the reasons for this decision [1][2]. Summary by Relevant Sections Transaction Details - The company planned to acquire 100% of Zhongke Shijie through a combination of issuing shares and cash, with a total valuation of 114 million yuan, reflecting a significant appraisal increase of 191.22% [2][3]. - The transaction was structured with 70% of the payment in shares (79.8 million yuan) and 30% in cash (34.2 million yuan) [3][4]. Financial Implications - The company intended to raise up to 40 million yuan through a private placement to cover the cash portion of the transaction and related costs, with the issuance not exceeding 30% of the total share capital prior to the transaction [5][6]. - The performance commitment for Zhongke Shijie includes net profits of no less than 33.36 million yuan, 50.76 million yuan, and 73.16 million yuan for the years 2025, 2026, and 2027, respectively, totaling at least 157.29 million yuan [10]. Company Performance - Fuhuang Steel Structure reported a revenue of 933 million yuan in Q1 2025, a year-on-year increase of 1.65%, with a net profit of 17 million yuan, up 4.04% [11]. - In 2024, the company experienced a revenue decline of 15.06% to 3.937 billion yuan, with a net profit drop of 46.51% to 51 million yuan [12]. Business Transition - The transaction aimed to facilitate Fuhuang Steel Structure's transition from traditional steel structure manufacturing to the high-speed visual perception and measurement technology sector, potentially enhancing its resilience and operational sustainability [13].

Core Viewpoint - The sixth Multinational Corporation Leaders Qingdao Summit highlighted the "Investment in China" investment exchange cooperation meeting, showcasing typical cases of multinational companies aiding Shandong's green, low-carbon, and high-quality development [1][4]. Group 1: Investment Projects - The investment exchange meeting presented 10 typical cases selected from 52 submissions across 16 cities in Shandong, demonstrating the collaborative efforts between multinational companies and Shandong in pursuing green development [4]. - SKF Group, the world's largest bearing manufacturer, invested 500 million yuan in Jinan to expand its factory and establish a global commercial vehicle R&D center [4]. - AstraZeneca, a Fortune 500 company, invested 750 million USD in Qingdao to build a zero-carbon inhalation aerosol production base and regional headquarters [4]. - Hexagon, the largest manufacturer of coordinate measuring instruments globally, invested 2.1 billion yuan in Qingdao to create a technology R&D center and Greater China headquarters [4]. Group 2: Strategic Partnerships - Kuwait Petroleum Company acquired a 25% stake in Wanhua Chemical through capital increase and merger, with foreign investment amounting to approximately 638 million USD [5]. - OSI Group, an American company, established its tenth factory in China in Weihai, with a total foreign investment exceeding 140 million USD over two years [6]. - Henkel, a Fortune 500 company, invested 120 million euros in Yantai to create its largest single investment project globally [7]. - Komatsu, another Fortune 500 company, invested 10.6 billion yuan to build a global smart manufacturing industrial base in Jining [8]. - Eagle Group from Singapore invested approximately 11 billion yuan in a 600,000-ton lyocell fiber project in Jining, while Asia Pacific Forestry's projects in Rizhao accumulated nearly 30 billion yuan in investment [8]. - ZF Friedrichshafen, a German Fortune 500 company, made three consecutive capital increases totaling 140 million euros to establish a safety airbag integrated project globally for the first time in Rizhao [8]. - Cigna Group, a Fortune 500 company, has cumulatively invested 580 million USD in a biotechnology project in Liaocheng, with 10 expansions since 2004 [9].

答：经过多年经营积累，公司现已形成智能水计量、智能热计量两 大主线、覆盖管网/户用全口径范围、近千种规格型号的产品体系， 广泛应用于城市供水、集中供热、消防安全等社会生活各个方面， 在节能减排、能效管理领域发挥重要作用。主要产品包括超声水表、 超声流量计、智能消火栓、超声热量表、智能衡流阀及其配套产品 等，现经营状况正常。 2.企业未来发展规划及前景如何？ 答：公司现拥有三大智能制造厂区，喜燕路厂区位于南京江宁滨江 经济开发区，占地 38 亩，拥有现代化成型产线；霍里山厂区位于马 鞍山雨山经济开发区，占地 92 亩，具备超大口径流量检定能力；在 建飞鹰路厂区位于南京江宁滨江经济开发区，占地 80 亩，将全面导 入智能工厂数字化生产线；智能计量仪表研发中心毗邻华东交通枢 纽南京南站，吸引高端研发技术人才加入，形成"一中心、三厂区" 的现代化发展布局，增强公司在超声计量领域的产业布局。公司管 理层对未来超声水表市场有信心，公司超声水表已经有超 10 年的应 用案例，产品质量稳定，且客户对超声水表的认可度越来越高，超 声水表推广效果达到预期，未来将会步入快速发展的通道。 3．公司智能超声热表类产品占比较小，未来在供 ...

Core Viewpoint - The report outlines the differentiated dividend distribution plan of Youlide Technology (China) Co., Ltd., confirming compliance with relevant laws and regulations, and indicating that the plan does not harm the interests of the company and its shareholders [5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is due to the company's decision to adjust the total cash dividend amount for the 2024 fiscal year, as announced on May 17, 2025 [1]. - The company has completed the registration of an additional 499,051 shares, increasing the total share capital from 111,281,997 shares to 111,781,048 shares [1]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of 10.00 yuan (including tax) for every 10 shares held, resulting in a total cash dividend distribution of 111,036,148 yuan (including tax) [2]. - The actual number of shares participating in the profit distribution is 111,036,148 shares after excluding 744,900 shares held in the repurchase account [2]. Group 3: Calculation Basis for Dividend Distribution - The reference price for ex-dividend trading is calculated using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [3]. - With a closing price of 34.20 yuan on May 21, 2025, the calculated cash dividend per share is approximately 1.0 yuan, resulting in an ex-dividend reference price of 33.20 yuan per share [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is negligible, remaining below 1% [4]. Group 4: Sponsor Institution's Review Opinion - The sponsor institution, Changcheng Securities, confirms that the differentiated dividend distribution complies with the Company Law, Securities Law, and other relevant regulations, ensuring no harm to the interests of the company and its shareholders [5].